Alisi et al. observed that circulating MCP-1 levels were higher in children with (biopsy-proven) non-alcoholic fatty liver disease than in age-matched obese controls and that these levels positively correlated with disease severity [35]. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.